These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29661164)
1. Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC). Dhont L; Pintilie M; Kaufman E; Navab R; Tam S; Burny A; Shepherd F; Belayew A; Tsao MS; Mascaux C BMC Cancer; 2018 Apr; 18(1):429. PubMed ID: 29661164 [TBL] [Abstract][Full Text] [Related]
2. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer. Harada H; Miyamoto K; Yamashita Y; Taniyama K; Mihara K; Nishimura M; Okada M Cancer Med; 2015 Oct; 4(10):1536-46. PubMed ID: 26276761 [TBL] [Abstract][Full Text] [Related]
3. Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Ko E; Lee BB; Kim Y; Lee EJ; Cho EY; Han J; Shim YM; Park J; Kim DH Clin Cancer Res; 2013 Mar; 19(5):1204-12. PubMed ID: 23319821 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer. Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer. Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908 [TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer. Philipp AB; Nagel D; Stieber P; Lamerz R; Thalhammer I; Herbst A; Kolligs FT BMC Cancer; 2014 Apr; 14():245. PubMed ID: 24708595 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of methylated free circulating DNA in colorectal cancer. Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391 [TBL] [Abstract][Full Text] [Related]
8. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer. Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880 [TBL] [Abstract][Full Text] [Related]
9. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer. Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357 [TBL] [Abstract][Full Text] [Related]
10. The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor? Dhont L; Mascaux C; Belayew A Cell Mol Life Sci; 2016 Jan; 73(1):129-47. PubMed ID: 26472339 [TBL] [Abstract][Full Text] [Related]
11. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer. Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375 [TBL] [Abstract][Full Text] [Related]
12. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Capouillez A; Debauve G; Decaestecker C; Filleul O; Chevalier D; Mortuaire G; Coppée F; Leroy X; Belayew A; Saussez S Histopathology; 2009 Jul; 55(1):77-90. PubMed ID: 19614770 [TBL] [Abstract][Full Text] [Related]
14. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer. Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702 [TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
17. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression. Bartolucci R; Wei J; Sanchez JJ; Perez-Roca L; Chaib I; Puma F; Farabi R; Mendez P; Roila F; Okamoto T; Taron M; Rosell R Clin Lung Cancer; 2009 Jan; 10(1):47-52. PubMed ID: 19289372 [TBL] [Abstract][Full Text] [Related]
18. Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer. Tao H; Tanaka T; Okabe K J Cancer Res Clin Oncol; 2017 Aug; 143(8):1449-1459. PubMed ID: 28382517 [TBL] [Abstract][Full Text] [Related]
19. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma. Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive value of HURP in non‑small cell lung cancer. Wang Q; Chen Y; Feng H; Zhang B; Wang H Oncol Rep; 2018 Apr; 39(4):1682-1692. PubMed ID: 29484418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]